Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The concept is scalable and can be extended to other diagnoses.
The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The complete workflow is supported by a tailor-made process control system.
The company, based in Sweden, became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications. It is listed on Euronext Growth Oslo under the ticker INIFY.
Company Details
- Employees
- 39
- Founded
- -
- Address
- Scheeles Väg 3, Solna,stockholm County 17165,sweden
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.inify.com
- Keywords
- Urology, Pathology, AI, Prostate Cancer, Digital Pathology, Machine Learning, Laboratory, Histology, Digital Process Control.
- HQ
- Solna, Stockholm County
Inify Laboratories Questions
Inify Laboratories's website is http://www.inify.com
Inify Laboratories's LinkedIn profile is https://se.linkedin.com/company/inify-laboratories
Inify Laboratories has
39 employees.
View email and phone details for 39
employees at Inify Laboratories.
Inify Laboratories's industry is
Hospitals and Health Care
Inify Laboratories's top competitors are
Ipercept,
Contextvision Ab,
Syntheticmr,
Embedl,
Frontpac Ab,
Umecrine Cognition Ab,
Svensk Förening För Patologi,
Synlab Sverige,
Stratipath,
Atlas Antibodies.
Inify Laboratories's categories are Hospitals and Health Care
Inify Laboratories's founding year is 2022
